Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Prieto

Showing results (571-580 of 657) with videos related to

Pageof 66
Sort By:
Pharmacogenetics and Genomics|March 16, 2006
Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanomaChunying Li, Derek Larson, Zhengdong Zhang, et al.
The American Journal of Surgical Pathology|February 8, 2013
Risk assessment for atypical spitzoid melanocytic neoplasms using FISH to identify chromosomal copy number aberrationsPedram Gerami, Richard A Scolyer, Xiaowei Xu, et al.
The American Journal of Surgical Pathology|November 24, 2016
Primary Cutaneous T-Cell Lymphomas Showing Gamma-Delta (γδ) Phenotype and Predominantly Epidermotropic Pattern are Clinicopathologically Distinct From Classic Primary Cutaneous γδ T-Cell LymphomasE Dean Merrill, Rose Agbay, Roberto N Miranda, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 14, 2006
Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysisChunying Li, Zhibin Hu, Zhensheng Liu, et al.
Journal of Cutaneous Pathology|June 30, 2019
Lichenoid dermatitis from immune checkpoint inhibitor therapy: An immune-related adverse event with mycosis-fungoides-like morphologic and molecular featuresMichael T Tetzlaff, Sherry Tang, Taylor Duke, et al.
Journal of Cutaneous Pathology|October 8, 2021
Diverse landscape of dermatologic toxicities from small-molecule inhibitor cancer therapyRiyad N H Seervai, Woo Cheal Cho, Emily Y Chu, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|January 11, 2023
Clinical outcome of Brazilian patients with non-small cell lung cancer in early stage harboring rare mutations in epidermal growth factor receptorJ Machado-Rugolo, C M Baldavira, T G Prieto, et al.
Cancers|November 6, 2019
Immunohistochemical and Molecular Features of Melanomas Exhibiting Intratumor and Intertumor Histomorphologic HeterogeneityHaider A Mejbel, Sri Krishna C Arudra, Dinesh Pradhan, et al.
Cancers|May 22, 2019
PD1/PD-L1 Expression in Blastic Plasmacytoid Dendritic Cell NeoplasmPhyu P Aung, Narittee Sukswai, Reza Nejati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic MelanomaMichael A Davies, Katherine Stemke-Hale, E Lin, et al.
Pageof 66

Showing results (571-580 of 657) with videos related to

Sort By:
Pageof 66
Pharmacogenetics and Genomics|March 16, 2006
Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanomaChunying Li, Derek Larson, Zhengdong Zhang, et al.
The American Journal of Surgical Pathology|February 8, 2013
Risk assessment for atypical spitzoid melanocytic neoplasms using FISH to identify chromosomal copy number aberrationsPedram Gerami, Richard A Scolyer, Xiaowei Xu, et al.
The American Journal of Surgical Pathology|November 24, 2016
Primary Cutaneous T-Cell Lymphomas Showing Gamma-Delta (γδ) Phenotype and Predominantly Epidermotropic Pattern are Clinicopathologically Distinct From Classic Primary Cutaneous γδ T-Cell LymphomasE Dean Merrill, Rose Agbay, Roberto N Miranda, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 14, 2006
Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysisChunying Li, Zhibin Hu, Zhensheng Liu, et al.
Journal of Cutaneous Pathology|June 30, 2019
Lichenoid dermatitis from immune checkpoint inhibitor therapy: An immune-related adverse event with mycosis-fungoides-like morphologic and molecular featuresMichael T Tetzlaff, Sherry Tang, Taylor Duke, et al.
Journal of Cutaneous Pathology|October 8, 2021
Diverse landscape of dermatologic toxicities from small-molecule inhibitor cancer therapyRiyad N H Seervai, Woo Cheal Cho, Emily Y Chu, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|January 11, 2023
Clinical outcome of Brazilian patients with non-small cell lung cancer in early stage harboring rare mutations in epidermal growth factor receptorJ Machado-Rugolo, C M Baldavira, T G Prieto, et al.
Cancers|November 6, 2019
Immunohistochemical and Molecular Features of Melanomas Exhibiting Intratumor and Intertumor Histomorphologic HeterogeneityHaider A Mejbel, Sri Krishna C Arudra, Dinesh Pradhan, et al.
Cancers|May 22, 2019
PD1/PD-L1 Expression in Blastic Plasmacytoid Dendritic Cell NeoplasmPhyu P Aung, Narittee Sukswai, Reza Nejati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic MelanomaMichael A Davies, Katherine Stemke-Hale, E Lin, et al.
Pageof 66